ANKRD22 and non-small cell lung carcinoma: Successive up-regulation of ANKRD22 was observed in adjacent, primary and metastatic carcinoma tissues in the same NSCLC patient, and high expression levels of ANKRD22 were significantly related to relapse and short OS time in NSCLC patients.